Information on new approvals and medication safety that rheumatologists need to know
Search results for: anakinra
Systemic Juvenile Idiopathic Arthritis
Changing treatment paradigms in the biologic era
A Duet of Bone and the Immune System
Examining emerging perspectives in osteoimmunology
New Guidance for Rheumatologists who Treat JIA
Evidence and consensus-based recommendations reflects current knowledge about initiation of therapy
ACR Honors Accomplishments in Rheumatology
Rheumatologists and health professionals recognized for their contributions to the field
Drug Updates
Information on New Approvals and Medication Safety
The Expanded Role of the Inflammasome in Human Disease
Exploring advances, evaluating what remains to be done
Aggressive Urate Lowering Needed for Gout
Patients with gout at increased risk for cardiovascular disease and adverse event
Meet the Model Biologics Policy
At its February meeting, the ACR board of directors approved the Model Biologics Policy, which will be used when discussing guidelines and patients’ quality of treatment with health insurance companies.
Cochrane Launches Journal Club with RA Article
Overview of studies on biologic use kicks off monthly literature review feature
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- Next Page »